Although epigenetic silencing of p53 seems rare in HNSCC56, the TP53 gene is found to be mutated in approximately 60% of all HNSCC, and its protein product p53 inactive in another 20% due to degradation by the human papilloma virus oncoprotein E6.44 This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.